Clinical Trials Microdosing Pharmaceutical 
The Joint Blog
NOVEMBER 15, 2021
While over the last few years, microdosing has become extremely popular, the act of microdosing has been recommended by experts for at least two decades. There are also many different substances that you can microdose, from psilocybin mushrooms to delta-8. In this article, we are going to cover microdose of legal substances.
Cannabis Law Report
FEBRUARY 14, 2020
a Canadian biotech firm, is entering Phase II clinical trials for two experimental treatments. According to its website, one trial involves an ibogaine-derived drug for treating opioid addiction. The other trial will test LSD microdosing as an ADHD treatment. Mind Medicine, Inc. ,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 19, 2022
Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.
Cannabis Law Report
FEBRUARY 10, 2022
A look at key research and clinical trials that were published in 2021, with analysis of themes like microdosing and SSRI interactions. I’m also particularly (and eternally) grateful to our Pharmaceutical Advisor Michael Haichin and Editor-at-Large Graham Pechenik. and Canada.
The Cannigma
JUNE 24, 2021
While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. These natural alternatives may also be effective as part of a daily “microdosing” regiment. Part of a natural, alternative lifestyle.
Cannabis Law Report
SEPTEMBER 10, 2019
Forbes reported on Hopkins researchers’ recommendation that, if psilocybin should clear Phase III clinical trials, the FDA should reclassify it from a Schedule I to a Schedule IV drug. Schedule I drugs have no accepted medical use, while Schedule IV drugs include pharmaceuticals such as benzodiazepines.
Cannabis Law Report
MARCH 3, 2022
The team at Microdose, the world’s biggest medical psychedelic conference , said the country’s move to permit Med Plant Science Ltd to produce psychedelic compounds makes it the first country to legalize all psychedelic medicine. . The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.
Expert insights. Personalized for you.
49 
Let's personalize your content